Best Beta-Blocker in Systolic Heart Failure, analysis of prognosis and evaluation of therapies
Not Applicable
- Conditions
- systolic heart failure
- Registration Number
- JPRN-UMIN000023944
- Lead Sponsor
- Chiba-Nishi General Hospital Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients who are considered not to be candidate for administration of beta blocker. 2)patients who are scheduled to undergo emergent dialysis or chronic dialysis patients. 3)patients who have developed acute coronary syndrome within 8 weeks before the registration day. 4)patients who need mechanical hemodynamical support (except for pace maker implantation OR ICD) 5)patients who have malignancy within 1 year prognosis. 6)patients who are pregnant, lactating, may become pregnant, or want to become pregnant during the study. 7)patients who are judged by an investor to be inappropriate for this study for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The composite endpoint of major adverse cardiac events (MACEs) OR rehospitalization for heart failure
- Secondary Outcome Measures
Name Time Method safety